SUMMARY An investigation was made of the effect of changing mean transit time (M1T) by administration of drugs which affect colonic motility on faecal microbial mass in man. Senokot was used to accelerate and codeine and/or loperamide to prolong transit in subjects maintained on a constant high fibre diet. Doses of Senokot or codeine/loperamide were adjusted to halve or double transit time measured during a three week control period on diet alone. Stools were collected throughout and analysed for bacterial mass by a gravimetric procedure. Transit was measured by a continuous marker method. Senokot decreased mean transit time from 63-9 to 25*0 hours (n=6), with increased stool weight from 148 to 285 g/day. Bacterial mass increased in all subjects from a mean of 16*5 to 20 3 g/day (dry weight) (p<0025). Codeine/loperamide increased mean transit time from 47 Ito 87 6 hours (n=5), with decreased stool weight from 182 to 119 g/day. Bacterial mass decreased in all but one subject from a mean of 18.9 to 16-1 g/day (NS). There was a significant correlation between transit time and bacterial mass in all three periods (r=0-77, p<0.001). Changes in transit time are shown to alter microbial growth in the human colon and result in altered stool output, on a constant diet. Factors which affect transit may be as important as diet in determining large bowel function and hence susceptibility to disease.
For subjects living on western diets, the main identifiable component of human colonic contents and faeces is the microflora. The human colon has been shown to contain roughly 230 g of bacteria,' and, considering the metabolic activity, interactions and production and utilisation of nutrients that this represents, the importance of the colonic microflora as a specialised metabolic compartment with a wide variety of functions has only recently been realised.
Faeces, the final product ofgastrointestinal activity, have been shown to comprise 55% bacteria on a dry weight basis for those consuming a western diet,' and as bacteria are about 80% water,' this represents roughly 70% of wet stool weight. The long held assumption that the main component of stools is undigested dietary residues must therefore now be reconsidered. Addrc The large proportion of bacteria in stools indicates that those factors which influence bacterial growth will have a dominating effect on total stool output. Indeed, the provision of carbohydrate, in the form of fermentable dietary fibre, results in increased bacterial growth, a large faecal bacterial mass and hence a larger stool bulk. ' Provision of substrate is not the only factor which influences bacterial cell growth, however. In studies where bacteria have been grown with a constant substrate supply, in in vitro continuous culture or in certain animal systems, such as the rumen, bacterial cell growth has also been found to depend on the turnover time, or dilution rate, of the system.' In studies of faecal microbial mass in human subjects, we have observed that both faecal output and faecal microbial mass vary considerably, in spite of subjects being on identical dietary intakes.' This variation has been found to be related to transit time through the gut, and, consistent with the in vitro and ruminant studies, more bacteria were excreted the faster the turnover rate." It therefore seems possible that transit 601 time through the colon has a marked influence on stool bulk in man independent of dietary intake. To test this hypothesis, we have altered the transit time of seven healthy volunteers by pharmacological means, while maintaining a constant dietary intake, and have measured the changes in faecal bacterial mass.
Methods

SUBJECTS
Seven healthy volunteers, four men and three women, aged 21-55 years, took part in the study. Six lived throughout the period of the study in the metabolic unit of the Dunn Clinical Nutrition Centre, Cambridge and carried out their normal work in or near Cambridge. The other subject lived at home, but received all his food daily from the metabolic kitchen and ate some of his meals there.
PROTOCOL
The study was divided into three three week periods, as shown in Figure 1 . For the whole of this time the subjects ate a controlled diet, collected their faeces and took radio-opaque pellets with each meal for the measurement of mean transit time and as balance markers. During the first three week period the diet only was taken, then in the subsequent periods, either Senokot (to speed up transit) or codeine/ loperamide (to slow down transit) were given in random order. Four subjects completed all three study periods while two managed control + Senokot and one control + codeine/loperamide. Faecal collections were continued for one week after the end of the study in order to recover all markers taken. Fig. 1 Protocol ofthe study. Diet only was given for thefirst three weeks. Senokot and/or codeinelloperamide were then given in random orderforsubsequent three week periods.
DIET
The diet was constant throughout the study, and consisted of three one day menus of similar composition fed in rotation ( Table 1 ). Figure 2 shows the daily values for two subjects during the three different experimental periods. Considerable variation occurs from day to 
MICROBIAL SOLIDS
Microbial solids were the largest fraction of faecal solids (45.8+3.9%) on the control diet. This proportion is not as great as in previous studies, where bacteria were found to represent 55% of faecal solids,2 because the greater fibre content of the present diet meant that a greater proportion of faecal solids consisted of undegraded fibre. Table 5 shows the changes in excretion of the components of bacterial solids with the Senokot and codeine/loperamide treatments. Faecal bacterial mass increased in every subject with the Senokot treatment, the mean change being from 16.5 g/day (dry weight) to 20-3 g/day (p<0025). With codeine/ loperamide, faecal bacterial mass decreased in all but one subject, the mean change being 18.9 g/day to 16-1 g/day (NS). A close relationship was found between microbial mass and mean transit time over all 3 periods (r=0-77, p<0.001) (Fig. 3 ). Table 5 also shows that the excretion of the water soluble fraction of stools increased with Senokot from 8-9 to 15.1 g/day (p<0-001) and decreased with codeine/loperamide, from 9-2 to 7-3 g/day (p<005).
FAECAL CARBOHYDRATE EXCRETION
The excretion of the individual sugar components making up the faecal carbohydrate are shown in Table 6 . Total faecal carbohydrate excretion for the .I 47 .7+10-6% (p<005). No significant changes in the digestibility of the other sugars were seen, nor were any significant differences observed in the codeine/ loperamide period.
Discussion
It is a widely held view at present that diet is the principal factor controlling large bowel function. As a result, it has been suggested that diet may play an important part in determining susceptibility to colonic disease in different populations in the world.18 Whilst good experimental evidence exists to show that altering dietary intake, especially of dietary fibre, alters bowel function significantly,'"22 there may be other important determinants of bowel function which could similarly influence susceptibility to disease.
In studies of bowel function of healthy individuals, we have observed marked differences between subjects despite their being on identical or similar diets.2"25 A three-fold range in stool weight, mean transit time,23 faecal ammonia concentration24 and bile acid excretion' has been found in healthy young men consuming diets which were virtually identical, while these ranges are even wider when more hetero- 5 contents is the microflora.' ' The control of microbial metabolism is therefore a key factor in explaining variations in colonic function. Because of the inaccessibility of the human colon, it is difficult to show changes in microbial metabolism in the gut itself, and it has been necessary to study the product of colonic metabolism, namely stools. By using a gravimetric procedure developed from animal work, it has been possible to investigate the effect of changes in diet on the size of the faecal bacterial population and we have shown that the colonic microflora responds to increases in fermentable carbohydrate supply by increasing cell numbers and mass. Numerous studies *in the ruminant and in vitro have shown, however, that the efficiency of anaerobic microbial growth is dependent, not only on substrate availability, but also on the rate of passage of material through the fermentation system. With a faster turnover rate, the more efficient is microbial growth and a greater mass of bacteria is produced. This is thought to be because the maintenance requirement of the resident bacterial population is reduced, and more of the available energy supply can be used for bacterial cell growth. The maintenance requirement of bacteria is always met in preference to growth and is that energy used for motility, replacement of lysed cells, maintenance of intracellular solute concentrations, active transport and turnover of intracellular constituents.' With changing dilution rates and turnover times, maintenance requirements may alter for a variety of reasons, for example if the size of the resident population changes, if the resident bacteria are in a different phase of growth, or if the resident bacteria are subjected to stressful environmental conditions, such as high concentrations of NH4CI." Irrespective of the reason for a change in the maintenance energy requirement, the result of such a change is to alter the amount of energy available for new cell growth.
The present investigation set out to determine whether bacterial growth in the human colon is similarly influenced by changes in turnover time. We examined this possibility by changing the transit time of healthy volunteers maintained on constant diets. Transit was altered using drugs which primarily affect gut motility and are not known to influence microbial activity directly. The drugs had to be effective, lack side effects, and be tolerated well by volunteers over extended periods. Senokot has been safely used for decades to treat constipation'7 whilst codeine phosphate is a well established drug commonly used to slow transit in diarrhoea. It was found, however, that speeding up transit was far easier than slowing it. The initial two tablets of Senokot were invariably not enough but once the dose was increased to three or four tablets per day a sustained rapid transit was achieved (Fig. 2) . To slow transit time all but one subject (the only woman) required more than 30 mg/day of codeine phosphate. Two subjects slowed with 60 mg/day but the other two had to be given loperamide in addition. Loperamide is a new anti-diarrhoeal agent which slows transit by a direct opiate-like inhibitory effect on peristaltic activity in the gut wall.'2 It does not influence fluid and electrolyte transport in unstimulated gut mucosa."
By altering the doses of these drugs appropriately, the desired changes in mean transit time were achieved, and significant alterations in colonic function were observed. Stool weight was increased with Senokot and reduced with codeine/loperamide. As in other studies where transit time and stool weight have been measured, an inverse relationship between the two was found.
The main purpose of the study was to investigate changes in microbial mass when transit was changed. With Senokot, the microbial fraction of stools was increased significantly, from 16-5 to 20 3 g/day, an increase of 25%. With codeine/loperamide, the microbial fraction fell from 18-9 to 16-1 g/day (20%), although this difference was not significant. These results suggest that, as predicted, altering transit time can result in a change in faecal microbial mass. Furthermore, a close relationship was found between transit time and microbial mass (Fig. 3) , indicating that even with manipulations of transit using drugs, the excretion of bacteria remains closely linked to the turnover time of the colon.
That these results reflect changing efficiency of bacterial cell growth depends on the supply of substrate being constant, which can be judged in part by examination of the intake and excretion of fermentable carbohydrate. With a constant diet throughout the study, dietary fibre and starch intakes were constant for each subject; from subject to subject, intakes of dietary fibre and starch also varied little, as foods containing dietary fibre were not included in the dietary increments, and the only incremented item which contained starch was the pudding on each day. The variation in starch intake from the lowest to highest energy intake was therefore only 9 g.
The faecal excretion of carbohydrate ( This study has shown that transit time has a major controlling influence over the colonic microflora and therefore over colonic function. Differences in bowel habit and microbial cell metabolism between individuals on similar diets are largely attributable to differences in mean transit time. Moreover the changes in bowel habit seen in these people due to mean transit time are of the same order or greater than those which can be induced by dietary manipulation. If diet is an important determinant of bowel function and disease so also must transit be, both acting through an effect on the microflora. The factors controlling transit itself, whether environmental or genetically determined, must therefore be important in affecting bowel function in both health and disease. 
